Tissue Plasminogen Activator in Critically Ill Adults with COVID-19

被引：0
|
作者：
Douin, David J. [1 ]
Shaefi, Shahzad [2 ]
Brenner, Samantha K. [3 ]
Gupta, Shruti [4 ]
Park, Isabel [4 ]
Wright, Franklin L.
Mathews, Kusum S. [5 ]
Chan, Lili [5 ]
Al-Samkari, Hanny [6 ]
Orfanos, Sarah [7 ]
Radbel, Jared [7 ]
Leaf, David E. [4 ]
机构：
[1] Univ Colorado, Sch Med, Aurora, CO 80045 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Hackensack Univ Med Ctr, Hackensack, NJ USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[6] Massachusetts Gen Hosp, Boston, MA 02114 USA
[7] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
来源：
ANNALS OF THE AMERICAN THORACIC SOCIETY | 2021年 / 18卷 / 11期
基金：
美国国家卫生研究院;
关键词：
VASOACTIVE-INOTROPIC SCORE; MORTALITY;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：1917 / 1921
页数：6
相关论文
共 50 条
  • [1] Management of Critically Ill Adults With COVID-19
    Poston, Jason T.
    Patel, Bhakti K.
    Davis, Andrew M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18): : 1839 - 1841
  • [2] Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial
    Rashidi, Farid
    Barco, Stefano
    Rezaeifar, Parisa
    Sadeghipour, Parham
    Ghodrati, Samad
    Bakhshandeh, Hooman
    Mousavi-Aghdas, Seyed Ali
    Sadeghi, Armin
    Sharifi, Akbar
    Valizadeh, Hamed
    Mikaeili, Haleh
    Rafiee, Farnaz
    Navarbaf, Zahar
    Farajian, Gita
    Mahmoodpoor, Ata
    Bikdeli, Behnood
    Ansarin, Khalil
    [J]. THROMBOSIS RESEARCH, 2022, 216 : 125 - 128
  • [3] Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
    Zuo, Yu
    Warnock, Mark
    Harbaugh, Alyssa
    Yalavarthi, Srilakshmi
    Gockman, Kelsey
    Zuo, Melanie
    Madison, Jacqueline A.
    Knight, Jason S.
    Kanthi, Yogendra
    Lawrence, Daniel A.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
    Yu Zuo
    Mark Warnock
    Alyssa Harbaugh
    Srilakshmi Yalavarthi
    Kelsey Gockman
    Melanie Zuo
    Jacqueline A. Madison
    Jason S. Knight
    Yogendra Kanthi
    Daniel A. Lawrence
    [J]. Scientific Reports, 11
  • [5] THE EFFECT OF A TISSUE PLASMINOGEN ACTIVATOR ON MYOCARDIAL INFARCTION THAT ARE POSITIVE FOR COVID-19
    Annie, Frank H.
    Embrey, Sarah
    Yasin, Muhammad
    Nanjundappa, Aravinda
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3084 - 3084
  • [6] Critically ill COVID-19 patient
    Halacli, Burcin
    Kaya, Akin
    Topeli, Arzu
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 : 585 - 591
  • [7] Nutrition guidelines for critically ill adults admitted with COVID-19: Is there consensus?
    Chapple, Lee-anne S.
    Tatucu-Babet, Oana A.
    Lambell, Kate J.
    Fetterplace, Kate
    Ridley, Emma J.
    [J]. CLINICAL NUTRITION ESPEN, 2021, 44 : 69 - 77
  • [8] Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19
    Smeets, Tim J. L.
    Valkenburg, Abraham J.
    van der Jagt, Mathieu
    Koch, Birgit C. P.
    Endeman, Henrik
    Gommers, Diederik A. M. P. J.
    Sassen, Sebastian D. T.
    Hunfeld, Nicole G. M.
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (07) : 973 - 983
  • [9] USE OF TISSUE PLASMINOGEN ACTIVATOR IN COVID-19 ARDS: A RETROSPECTIVE CASE SERIES
    Nemeh, Christopher
    Lavere, Philip
    Deleija, Juan
    Salem, Ahmed
    Alapat, Philip
    [J]. CHEST, 2021, 160 (04) : 1028A - 1028A
  • [10] Nursing Surge Capacity Strategies for Management of Critically Ill Adults with COVID-19
    Al Mutair, Abbas
    Amr, Anas
    Ambani, Zainab
    Al Salman, Khulud
    Schwebius, Deborah
    [J]. NURSING REPORTS, 2020, 10 (01) : 23 - 32
12345